The Importance of Post-Inflammatory Polyps (PIPs) in Colorectal Cancer Surveillance in Inflammatory Bowel Diseases

Overview

Journal J Clin Med

Date 2025 Jan 25

PMID 39860339

Authors

Ivanna Candel

Panu Wetwittayakhlang

Talat Bessissow

Peter L Lakatos

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel diseases (IBDs), encompassing Ulcerative Colitis (UC) and Crohn's Disease (CD), are chronic inflammatory disorders affecting the gastrointestinal tract. The association between IBD and colorectal cancer (CRC) is well-documented. Multiple factors have been identified as contributors to the risk of developing CRC in patients with IBD, including duration of disease, disease extension, family history of CRC, co-existance of primary sclerosing cholangitis (PSC), and potentially the presence of post-inflammatory polyps (PIPs). PIPs, often referred to as pseudopolyps, are polypoid structures that emerge as a result of severe mucosal inflammation. While their presence has been linked to greater disease severity, the role of PIPs in increasing CRC risk remains controversial. Increasing evidence suggests an association between post-inflammatory polyps (PIPs) and the risk of colorectal neoplasia, with PIPs potentially serving as an indicator of this risk through a history of enhanced inflammation. PIPs may also be linked to a distinct patient phenotype, including the presence of other known risk factors. More recent studies suggest that the risk burden (characterized by a high number or by large polyps) may be important. However, the evidence remains inconsistent, with some studies showing no clear association between PIPs and CRC risk after adjusting for other factors, including histological inflammation. In contrast, the data suggest a low rate of malignant transformation of the PIPs themselves. This narrative review aims to summarize the latest evidence regarding the relationship between PIPs and CRC in IBD, with a focus on UC. While some studies suggest that PIPs may serve as markers of higher disease severity and inflammation, their direct contribution to CRC risk remains unclear. Further research is needed to explore the inflammatory and carcinogenic pathways in patients with PIPs to better understand their role in colorectal cancer (CRC) development.

References

Teague R, Read A . Polyposis in ulcerative colitis. Gut. 1975; 16(10):792-5. PMC: 1413089. DOI: 10.1136/gut.16.10.792. View

Levine D, Surawicz C, Spencer G, Rohrmann C, Silverstein F . Inflammatory polyposis two years after ischemic colon injury. Dig Dis Sci. 1986; 31(10):1159-67. DOI: 10.1007/BF01300268. View

Maggs J, Browning L, Warren B, Travis S . Obstructing giant post-inflammatory polyposis in ulcerative colitis: Case report and review of the literature. J Crohns Colitis. 2010; 2(2):170-80. DOI: 10.1016/j.crohns.2007.10.007. View

Annese V, Daperno M, Rutter M, Amiot A, Bossuyt P, East J . European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013; 7(12):982-1018. DOI: 10.1016/j.crohns.2013.09.016. View

Hogan W, HENSLEY G, GEENEN J . Endoscopic evaluation of inflammatory bowel disease. Med Clin North Am. 1980; 64(6):1083-102. DOI: 10.1016/s0025-7125(16)31557-7. View

Choi C, Rutter M, Askari A, Lee G, Warusavitarne J, Moorghen M . Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview. Am J Gastroenterol. 2015; 110(7):1022-34. PMC: 4517513. DOI: 10.1038/ajg.2015.65. View

de Jong M, Gillis V, Derikx L, Hoentjen F . No Increased Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease and Postinflammatory Polyps. Inflamm Bowel Dis. 2019; 26(9):1383-1389. PMC: 7441099. DOI: 10.1093/ibd/izz261. View

Lutgens M, van Oijen M, van der Heijden G, Vleggaar F, Siersema P, Oldenburg B . Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013; 19(4):789-99. DOI: 10.1097/MIB.0b013e31828029c0. View

Murthy S, Feuerstein J, Nguyen G, Velayos F . AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review. Gastroenterology. 2021; 161(3):1043-1051.e4. DOI: 10.1053/j.gastro.2021.05.063. View

10.

Hassan C, Spadaccini M, Iannone A, Maselli R, Jovani M, Chandrasekar V . Performance of artificial intelligence in colonoscopy for adenoma and polyp detection: a systematic review and meta-analysis. Gastrointest Endosc. 2020; 93(1):77-85.e6. DOI: 10.1016/j.gie.2020.06.059. View

11.

Rezapour M, Quintero M, Khakoo N, Sussman D, Barkin J, Clarke J . Reclassifying Pseudopolyps in Inflammatory Bowel Disease: Histologic and Endoscopic Description in the New Era of Mucosal Healing. Crohns Colitis 360. 2019; 1(3):otz033. PMC: 6798790. DOI: 10.1093/crocol/otz033. View

12.

MARKS R, Roberts-Thomson I . Gastrointestinal: colonic pseudopolyposis. J Gastroenterol Hepatol. 2000; 15(2):213. DOI: 10.1046/j.1440-1746.2000.02085.x. View

13.

Jalan K, Walker R, Sircus W, MCMANUS J, Prescott R, CARD W . Pseudopolyposis in ulcerative colitis. Lancet. 1969; 2(7620):555-9. DOI: 10.1016/s0140-6736(69)90260-8. View

14.

Soderlund S, Brandt L, Lapidus A, Karlen P, Brostrom O, Lofberg R . Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology. 2009; 136(5):1561-7. DOI: 10.1053/j.gastro.2009.01.064. View

15.

Kelly J, Gabos S . The pathogenesis of inflammatory polyps. Dis Colon Rectum. 1987; 30(4):251-4. DOI: 10.1007/BF02556166. View

16.

Adami H, Bretthauer M, Emilsson L, Hernan M, Kalager M, Ludvigsson J . The continuing uncertainty about cancer risk in inflammatory bowel disease. Gut. 2016; 65(6):889-93. PMC: 5226357. DOI: 10.1136/gutjnl-2015-311003. View

17.

Kyung Chang D, Kim J, Choi H, Eun C, Han D, Byeon J . Double balloon endoscopy in small intestinal Crohn's disease and other inflammatory diseases such as cryptogenic multifocal ulcerous stenosing enteritis (CMUSE). Gastrointest Endosc. 2007; 66(3 Suppl):S96-8. DOI: 10.1016/j.gie.2007.01.016. View

18.

Wetwittayakhlang P, Golovics P, Gonczi L, Lakatos L, Lakatos P . Stable Incidence and Risk Factors of Colorectal Cancer in Ulcerative Colitis: A Population-Based Cohort Between 1977-2020. Clin Gastroenterol Hepatol. 2023; 22(1):191-193.e3. DOI: 10.1016/j.cgh.2023.03.022. View

19.

Fitterer J, Cromwell L, Sims J . Colonic obstruction by giant pseudopolyposis. Gastroenterology. 1977; 72(1):153-6. View

20.

Ferguson C, Balfour T, PADFIELD C . Localized giant pseudopolyposis of the colon in ulcerative colitis. Report of a case. Dis Colon Rectum. 1987; 30(10):802-4. DOI: 10.1007/BF02554631. View